Loading...
Last submissions
-
-
Thomas Grinda, Alison Antoine, William Jacot, Paul-Henri Cottu, Thibault de la Motte Rouge, et al.. Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort. European Journal of Cancer, 2023, 189, pp.112935. ⟨10.1016/j.ejca.2023.05.023⟩. ⟨hal-04205902⟩
-
Rose-Marie Fraboulet, Yanis Si Ahmed, Marc Aubry, Sébastien Corre, Marie-Dominique Galibert, et al.. Cirscan: a shiny application to identify differentially active sponge mechanisms and visualize circRNA-miRNA-mRNA networks. JOURNÉES OUVERTES EN BIOLOGIE, INFORMATIQUE ET MATHÉMATIQUES (JOBIM ) 2023, Jun 2023, Diverses villes françaises, France. ⟨hal-04286509⟩
-
Roch Houot, Emmanuel Bachy, Guillaume Cartron, François-Xavier Gros, Franck Morschhauser, et al.. Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial. Nature Medicine, 2023, ⟨10.1038/s41591-023-02572-5⟩. ⟨hal-04212634⟩
-
Aziz Zaanan, Julie Henriques, Anthony Turpin, Sylvain Manfredi, Romain Coriat, et al.. Adjuvant chemotherapy benefit according to T and N stage in small bowel adenocarcinoma: a large retrospective multicenter study. JNCI Cancer Spectrum, 2023, 7 (5), pkad064. ⟨10.1093/jncics/pkad064⟩. ⟨hal-04282951⟩
-
Caroline Gelabert, Panagiotis Papoutsoglou, Irene Golan, Eric Ahlstrom, Adam Ameur, et al.. The long non-coding RNA LINC00707 interacts with Smad proteins to regulate TGFβ signaling and cancer cell invasion. Cell Communication and Signaling, 2023, 21 (1), pp.271. ⟨10.1186/s12964-023-01273-3⟩. ⟨hal-04279031⟩
-
Alexandre Bourdiol, Vincent Legros, Fanny Vardon-Bounes, Thomas Rimmele, Paul Abraham, et al.. Prevalence and risk factors of significant persistent pain symptoms after critical care illness: a prospective multicentric study. Critical Care, 2023, 27 (1), pp.199. ⟨10.1186/s13054-023-04491-w⟩. ⟨hal-04141716⟩
-
-
Mathilde Cancel, Gaelle Fromont, Cyriac Blonz, Christine Chevreau, Nathalie Rioux-Leclercq, et al.. Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d'Etude des Tumeurs Uro-Genitales). European Journal of Cancer, 2021, 158, pp.1-11. ⟨10.1016/j.ejca.2021.08.046⟩. ⟨hal-04242387⟩
-
-
-
Maxime K Collard, Jérémie Bardin, Bertille Marquet, Michel Laurin, Éric Ogier-Denis. Correlation between the presence of a cecal appendix and reduced diarrhea severity in primates: new insights into the presumed function of the appendix. Scientific Reports, 2023, 13 (1), pp.15897. ⟨10.1038/s41598-023-43070-5⟩. ⟨hal-04226713⟩
-
-
-
-
Véronique Vendrely, Philippe Ronchin, Mathieu Minsat, Karine Le Malicot, Claire Lemanski, et al.. Panitumumab in combination with chemoradiotherapy for the treatment of locally-advanced anal canal carcinoma: Results of the FFCD 0904 phase II trial. Radiotherapy & Oncology, 2023, 186, pp.109742. ⟨10.1016/j.radonc.2023.109742⟩. ⟨hal-04163679⟩
-
-
Manon Baty, David Pasquier, Khemara Gnep, Joël Castelli, Nolewenn Delaby, et al.. Achievable Dosimetric Constraints in Stereotactic Reirradiation for Recurrent Prostate Cancer. Practical Radiation Oncology: An official journal of the American Society for Radiation Oncology, 2023, ⟨10.1016/j.prro.2023.05.007⟩. ⟨hal-04164898⟩
-
-